Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia

NCT: NCT05225935 · COMPLETED

NCT IDNCT05225935
StatusCOMPLETED
Start Date2022-06-29
Completion2024-12-20

Brief Summary

This double arm randomized study will compare 2 ventricular tachycardia ablation strategies: the standard strategy based on invasive substrate and VT mapping with 3D electro-anatomical system vs a tailored strategy which identifies targets based on pre-procedural CT-scan imaging. The primary endpoint will be procedure duration and secondary endpoints will include safety and efficacy criteria as well as medico-economic evaluation.

Frequently Asked Questions

What is Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia?

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia is a clinical trial registered under NCT05225935. Current status: COMPLETED.

What is the status of NCT05225935?

The current status of NCT05225935 (Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia) is: COMPLETED.

When did Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia start?

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia started on 2022-06-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑